Performance of the Molecular International Prognostic Scoring System (IPSS-M) in Hypomethylating Agent-Treated Patients with Myelodysplastic Syndromes

被引:0
|
作者
Chien, Kelly S. [1 ]
Urrutia, Samuel [2 ]
Li, Ziyi [3 ]
Kanagal-Shamanna, Rashmi [4 ]
Abdelhakeem, Ahmed [1 ]
Abuasab, Tareq [1 ]
Almanza, Emmanuel [1 ]
Gener-Ricos, Georgina [1 ]
Bataller, Alex [1 ]
Bazinet, Alexandre [1 ]
Montalban-Bravo, Guillermo [1 ]
Short, Nicholas J. [1 ]
Jabbour, Elias [1 ]
Kadia, Tapan M. [1 ]
Ravandi, Farhad [1 ]
Borthakur, Gautam [1 ]
Hammond, Danielle E. [1 ]
Swaminathan, Mahesh [1 ]
Sasaki, Koji [1 ]
Dong, Xiao Qin [1 ]
Pierce, Sherry [1 ]
Kantarjian, Hagop [1 ]
Garcia-Manero, Guillermo [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2023-189557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
    A Nazha
    M Narkhede
    T Radivoyevitch
    D J Seastone
    B J Patel
    A T Gerds
    S Mukherjee
    M Kalaycio
    A Advani
    B Przychodzen
    H E Carraway
    J P Maciejewski
    M A Sekeres
    Leukemia, 2016, 30 : 2214 - 2220
  • [22] Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
    Nazha, A.
    Narkhede, M.
    Radivoyevitch, T.
    Seastone, D. J.
    Patel, B. J.
    Gerds, A. T.
    Mukherjee, S.
    Kalaycio, M.
    Advani, A.
    Przychodzen, B.
    Carraway, H. E.
    Maciejewski, J. P.
    Sekeres, M. A.
    LEUKEMIA, 2016, 30 (11) : 2214 - 2220
  • [23] Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
    Mishra, Asmita
    Corrales-Yepez, Maria
    Al Ali, Najla
    Kharfan-Dabaja, Mohamed
    Padron, Eric
    Zhang, Ling
    Epling-Burnette, Pearlie K.
    Pinilla-Ibarz, Javier
    Lancet, Jeffrey E.
    List, Alan F.
    Komrokji, Rami S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (07) : 566 - 570
  • [24] CLINICIAN UTILIZATION OF THE INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS) FOR NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS
    Pease, D.
    Ross, J.
    Poynter, J.
    Nguyen, P.
    Hirsch, B.
    Cioc, A.
    Roesler, M.
    Warlick, E.
    LEUKEMIA RESEARCH, 2015, 39 : S118 - S118
  • [25] Application of the international scoring system (IPSS) for myelodysplastic syndromes (MDS).
    Maes, B
    Meeus, P
    Bijnens, L
    Boogaerts, M
    Hagemeijer, A
    De Wolf-Peeters, C
    Verhoef, F
    BLOOD, 1998, 92 (10) : 252B - 253B
  • [26] REPORT ON OUTCOME OF HYPOMETHYLATING THERAPY WITH ANALYSIS ON PROGNOSTIC VALUE OF REVISED-INTERNATIONAL PROGNOSTIC SCORING SYSTEM IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES OF LOWER-RISK BASED ON IPSS
    Lee, Y.
    Moon, J.
    Yoon, J.
    Kim, J.
    Sohn, S.
    HAEMATOLOGICA, 2016, 101 : 507 - 507
  • [27] The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromes
    Nazha, Aziz
    Seastone, David P.
    Keng, Michael
    Hobson, Sean
    Kalaycio, Matt
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    LEUKEMIA & LYMPHOMA, 2015, 56 (12) : 3437 - 3439
  • [28] Revised International Prognostic Scoring System (IPSS-R), stratification for myelodysplastic syndrome (MDS) patients under hypomethylating treatment
    Iastrebner, M.
    Flores, G.
    Nucifora, E.
    Kornblihtt, L.
    Alfonso, G.
    Rosenhain, M.
    Benasayag, S.
    Barcala, V.
    Garcia Rivello, H.
    Belli, C.
    LEUKEMIA RESEARCH, 2013, 37 : S85 - S85
  • [29] DOES REVISED INTERNATIONAL PROGNOSITIC SCORING SYSTEM (IPSS-R) HAVE ANY IMPACT ON CLINICAL OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS?
    Teo, Z.
    Yiu, R.
    Yueh, L. Ling
    Ho, A.
    HAEMATOLOGICA, 2013, 98 : 312 - 313
  • [30] APPLICATION OF THE MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS-M) MODEL IN SOUTH-AMERICAN MDS PATIENTS: A STUDY FROM ARGENTINA AND URUGUAY
    Lincango, M.
    Andreoli, V.
    Rivello, H. Garcia
    Asinari, M.
    Bender, A.
    Alfero, C.
    Catalan, A.
    Rahhal, M.
    Delamer, R.
    Osorio, M. J. Mela
    Navickas, A.
    Grille, S.
    Agriello, E.
    Castro, M.
    Perusini, M. A.
    Arbelbide, J.
    Basquiera, A.
    Belli, C.
    LEUKEMIA RESEARCH, 2023, 128